Literature DB >> 16170814

Use of gel microcolumn assay for the detection of drug-induced positive direct antiglobulin tests.

M C Z Novaretti1, C R Sopeleti, P E Dorlhiac-Llacer, D A F Chamone.   

Abstract

Drugs can result in broad variety of hematologic abnormalities including positive direct antiglobulin test. In this study, we evaluated gel microcolumn assay for the detection of drug-induced antibodies. Direct antiglobulin test was performed by conventional tube and by gel microcolumn assay in 139 hospitalized patients. Drug in vitro studies were done in 34 patients with positive direct antiglobulin test by tube test and gel microcolumn assay using serum and eluate. None of them had signs of hemolytic anemia. A total of 1,000 blood samples from donors were used as control group. Gel microcolumn assay was more sensitive than in tube test for direct antiglobulin test (P<0.01). Positive direct antiglobulin test was more frequent in patients than in donors (P<0.01). Drug in vitro studies were positive with at least one drug in 76.5% of patients with positive direct antiglobulin test by immune complex and/or adsorption mechanisms. We found a high incidence of positive drug in vitro tests in positive direct antiglobulin test patients. Gel microcolumn assay showed appropriate results for drug in vitro studies. The combination of tube and gel microcolumn assay can improve detection of drug-induced positive direct antiglobulin tests. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170814      PMCID: PMC6807894          DOI: 10.1002/jcla.20081

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  43 in total

Review 1.  Laboratory investigation of autoimmune hemolytic anemias.

Authors:  M S Wright; L A Smith
Journal:  Clin Lab Sci       Date:  1999 Mar-Apr

2.  The direct antiglobulin test: still a place for the tube technique?

Authors:  J D Tissot; C Kiener; B Burnand; P Schneider
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

3.  Drug-induced immune hemolytic anemia.

Authors:  L D Petz; C Mueller-Eckhardt
Journal:  Transfusion       Date:  1992 Mar-Apr       Impact factor: 3.157

4.  Death from drug-induced hemolytic anemia.

Authors:  R Taraszewski; R Harvey; P Rosman
Journal:  Postgrad Med       Date:  1989-05-15       Impact factor: 3.840

5.  Immune hemolytic anemia associated with tolmetin and suprofen.

Authors:  B A van Dijk; P B Rico; A Hoitsma; V A Kunst
Journal:  Transfusion       Date:  1989-09       Impact factor: 3.157

6.  Use of the gel test to detect mixed red blood cell populations in bone marrow transplantation patients.

Authors:  M C Zago-Novaretti; F L Dulley; P E Dorlhiac-Lacer; D A Chamone
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

7.  Column agglutination technology: the antiglobulin test.

Authors:  K J Reis; R Chachowski; A Cupido; D Davies; J Jakway; T M Setcavage
Journal:  Transfusion       Date:  1993-08       Impact factor: 3.157

8.  Fatal immune haemolysis due to a degradation product of ceftriaxone.

Authors:  O Meyer; H Hackstein; B Hoppe; F J Göbel; G Bein; A Salama
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

9.  Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis.

Authors:  A Salama; B Göttsche; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1991-04       Impact factor: 6.998

Review 10.  Allergic reactions in man.

Authors:  C W Parker
Journal:  Pharmacol Rev       Date:  1982-03       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.